These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 14195200

  • 1. DRUG SYNERGISM IN ANTINEOPLASTIC CHEMOTHERAPY.
    VENDITTI JM, GOLDIN A.
    Adv Chemother; 1964; 13():397-498. PubMed ID: 14195200
    [No Abstract] [Full Text] [Related]

  • 2. CHEMOTHERAPY OF ADVANCED MOUSE LEUKEMIA L1210: COMPARISON OF METHOTREXATE ALONE AND IN SEQUENTIAL THERAPY.
    VENDITTI JM, GOLDIN A.
    Cancer Res; 1964 Sep; 24():1457-60. PubMed ID: 14221802
    [No Abstract] [Full Text] [Related]

  • 3. THE CORRELATION BETWEEN TRANSPLANTED MOUSE AND HUMAN ACUTE LEUKEMIAS.
    BURCHENAL JH, OETTGEN HF, LYMAN M, PURPLE J.
    Acta Unio Int Contra Cancrum; 1964 Sep; 20():256-9. PubMed ID: 14151900
    [No Abstract] [Full Text] [Related]

  • 4. THE EFFECT OF A PHTHALANILIDE DERIVATIVE ON LIPIDE METABOLISM IN L1210 LEUKEMIA CELLS.
    GELLHORN A, WAGNER M, RECHLER M, KOREN Z, BENJAMIN W.
    Cancer Res; 1964 Apr; 24():400-8. PubMed ID: 14147813
    [No Abstract] [Full Text] [Related]

  • 5. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ.
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract] [Full Text] [Related]

  • 6. DEVELOPMENT AND PROPERTIES OF MOUSE LEUKEMIA L1210 RESISTANT TO MIRACIL D.
    HIRSCHBERG E, BRINDLE SD, SEMENTE G.
    Cancer Res; 1964 Nov; 24():1733-7. PubMed ID: 14230920
    [No Abstract] [Full Text] [Related]

  • 7. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J, Robak T.
    Acta Haematol Pol; 1993 Nov; 24(2):177-82. PubMed ID: 8103959
    [Abstract] [Full Text] [Related]

  • 8. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J, Robak T, Warzocha K, Grieb P.
    Arch Immunol Ther Exp (Warsz); 1994 Nov; 42(1):39-42. PubMed ID: 7503633
    [Abstract] [Full Text] [Related]

  • 9. AN EXPERIMENTAL THERAPEUTIC APPROACH TO L1210 LEUKEMIA IN MICE: COMBINED CHEMOTHERAPY AND CENTRAL NERVOUS SYSTEM IRRADIATION.
    JOHNSON RE.
    J Natl Cancer Inst; 1964 Jun; 32():1333-41. PubMed ID: 14191403
    [No Abstract] [Full Text] [Related]

  • 10. [L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
    Pouillart P, Huong TH, Lhéritier J.
    Bull Cancer; 1974 Jun; 61(4):509-26. PubMed ID: 4458834
    [No Abstract] [Full Text] [Related]

  • 11. Timing- and sequence-dependent synergism between etoposide and methotrexate or etoposide, methotrexate and 5-fluorouracil in advanced leukemia L1210.
    Osswald H, Herrmann R, Youssef M.
    Cancer Lett; 1985 Dec; 29(3):277-82. PubMed ID: 4075296
    [Abstract] [Full Text] [Related]

  • 12. THE EFFECT OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE HYDROCHLORIDE ON MURINE NEOPLASMS.
    EVANS JS, MUSSER EA, BOSTWICK L, MENGEL GD.
    Cancer Res; 1964 Aug; 24():1285-93. PubMed ID: 14216163
    [No Abstract] [Full Text] [Related]

  • 13. [The effect of benzylpenicillin and doxycycline on toxicity and antineoplastic action of cyclophosphamide and methotrexate in mice].
    Pakulska W.
    Acta Pol Pharm; 1992 Aug; 49(1-2):35-40. PubMed ID: 8769079
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of combination chemotherapy with three drugs.
    Goldin A, Venditti JM, Mantel N, Kline I, Gang M.
    Cancer Res; 1968 May; 28(5):950-60. PubMed ID: 5652309
    [No Abstract] [Full Text] [Related]

  • 15. SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
    EVANS JS, BOSTWICK L, MENGEL GD.
    Biochem Pharmacol; 1964 Jul; 13():983-8. PubMed ID: 14201140
    [No Abstract] [Full Text] [Related]

  • 16. The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents.
    Woodman RJ, Sirica AE, Gang M, Kline I, Venditti JM.
    Chemotherapy; 1973 Jul; 18(3):169-83. PubMed ID: 4119363
    [No Abstract] [Full Text] [Related]

  • 17. THERAPEUTIC AND IMMUNOLOGICAL RESPONSE OF MICE WITH MENINGEAL LEUKEMIA (L1210) TO CHALLENGE WITH AN ANTIFOLIC-RESISTANT VARIANT.
    CHIRIGOS MA, THOMAS LB, HUMPHREYS SR, GLYNN JP, GOLDIN A.
    Cancer Res; 1964 Apr; 24():409-15. PubMed ID: 14147814
    [No Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA, Sirotnak FM, Otter GM, DeGraw JI.
    Cancer Treat Rep; 1987 Apr; 71(7-8):727-32. PubMed ID: 3607784
    [Abstract] [Full Text] [Related]

  • 19. EVALUATION OF ANTILEUKEMIC AGENTS EMPLOYING ADVANCED LEUKEMIA L1210 IN MICE. 8.
    VENDITTI JM, KLINE I, GOLDIN A.
    Cancer Res; 1964 Jul; 24():827-79. PubMed ID: 14204394
    [No Abstract] [Full Text] [Related]

  • 20. Investigation of the activity of cytoxan against leukemia L1210 in mice.
    VENDITTI JM, HUMPHREYS SR, GOLDIN A.
    Cancer Res; 1959 Oct; 19():986-95. PubMed ID: 13841661
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.